Close
  Indian J Med Microbiol
 

Figure 2: Morphology of HeLa cells observed under fluorescent cell imager using brightfield mode with ×20 objective len (ZOE™ fluorescent cell imager) after 24 h treatment. Row A represents the incubation of HeLa cell in the control group, with the treatment of (Aa) supplement free media (negative control), (Ab) 62.5 μg/ml of doxorubicin and (Ac) 50 μM of trolox. Row B represents the incubation of HeLa cell with Leucaena leucocephala extracted at different concentrations of (Ba) 62.5, (Bb) 125 and (Bc) 250 μg/ml. Row C represents the incubation of HeLa cell with Dracaena serrulata extracted at different concentrations of (Ca) 62.5, (Cb) 125 and (Cc) 250 μg/ml (left to right)

Figure 2: Morphology of HeLa cells observed under fluorescent cell imager using brightfield mode with ×20 objective len (ZOE™ fluorescent cell imager) after 24 h treatment. Row A represents the incubation of HeLa cell in the control group, with the treatment of (Aa) supplement free media (negative control), (Ab) 62.5 μg/ml of doxorubicin and (Ac) 50 μM of trolox. Row B represents the incubation of HeLa cell with <i>Leucaena leucocephala</i> extracted at different concentrations of (Ba) 62.5, (Bb) 125 and (Bc) 250 μg/ml. Row C represents the incubation of HeLa cell with <i>Dracaena serrulata</i> extracted at different concentrations of (Ca) 62.5, (Cb) 125 and (Cc) 250 μg/ml (left to right)